Brawn Biotech, a company in the Pharmaceuticals industry, reported revenue of ₹5.62 crore and net profit of ₹0.03 crore for the September 2026 quarter.
Brawn Biotech (BSE: BRAWN) closed at ₹20.25 on 20 Nov 2026, down 3.6% over the past year. Its market capitalisation is ₹6 crore and it trades at 7.5 times earnings.
Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.